Stockreport

Vyriad announces strategic collaboration with Novartis to develop in vivo CAR-T cell therapies [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF The collaboration will utilize Vyriad's targeted lentiviral vector platform and Novartis' expertise in cell therapy innovation to identify and develop CAR-T cell therapy [Read more]